Disease details

Clinical trials : 3,342 / Drugs : 2,355 - (DrugBank : 406) / Drug target genes : 269 - Drug target pathways : 241

2 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00965497 (ClinicalTrials.gov)	July 2009	7/8/2009	Escitalopram (Lexapro) for Depression MS or ALS	An Open-label, 8- Week, Flexible Dose Trial of Escitalopram (Lexapro®) in Comorbid Major Depression With Amyotrophic Lateral Sclerosis and Multiple Sclerosis	Major Depression;Multiple Sclerosis;Amyotrophic Lateral Sclerosis	Drug: escitalopram	University of South Carolina	NULL	Completed	18 Years	70 Years	All	13	Phase 3	United States
2	NCT00151294 (ClinicalTrials.gov)	November 2004	6/9/2005	The Efficacy and Safety of Escitalopram for Depression in Multiple Sclerosis	A Double-Blind, Placebo-Controlled Investigation Into the Safety and Efficacy of Escitalopram for Depression in Multiple Sclerosis	Depression;Multiple Sclerosis	Drug: escitalopram oxalate antidepressant	Weill Medical College of Cornell University	Forest Laboratories	Terminated	18 Years	N/A	Both	20	Phase 4	United States